Supplementary Table 2 from Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates
收藏NIAID Data Ecosystem2026-05-01 收录
数据链接：
官方服务：
资源简介：
Supplementary Table 2. Antibodies and dilutions used in Cyclic Immunofluorescence (CyCIF) with vendor, catalogue number, and dilution used for each marker.
创建时间：
2024-04-01
